13F-HR/A filed by JOHNSON & JOHNSON
JOHNSON & JOHNSON filed this 13F-HR/A for the quarter ended 2025-12-31, filed 2026-03-18, with 17 holding rows worth $555,047,952.
- Accession
- 0000904454-26-000192
- Filer
- CIK 200406
- Filed
- 2026-03-18
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2025
A holdings report, amendment of type restatement, 17 entries on the cover page, a total value of $555,047,952 stated on the cover page (in dollars after the unit check, H1), rows summing to $555,047,952 with VALUE read as dollars as filed, 13F file number 028-20072. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerJohnson & Johnson Innovation - JJDC, Inc.028-20073
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 2,449,183 | $213,911,643 | dollars as filed | |
| NANOBIOTIX | 63009J107 | SPONSORED ADS | 5,623,816 | $130,022,626 | dollars as filed | |
| RAPPORT THERAPEUTICS INC COM | 75383L102 | Stock | 1,784,517 | $54,142,246 | dollars as filed | |
| MEIRAGTX HOLDINGS PLC | G59665102 | COMMON STOCK | 6,641,064 | $52,796,459 | dollars as filed | |
| CVRX INC | 126638105 | COMMON STOCK | 4,024,861 | $28,576,513 | dollars as filed | |
| CONTINEUM THERAPEUTICS INC CL A | 21217B100 | Stock | 1,979,173 | $22,621,947 | dollars as filed | |
| LEGEND BIOTECH CORP | 52490G102 | SPONSORED ADS | 814,586 | $17,709,100 | dollars as filed | |
| XENCOR INC | 98401F105 | COMMON STOCK | 748,062 | $11,452,829 | dollars as filed | |
| PROCEPT BIOROBOTICS CORP COM | 74276L105 | Stock | 357,939 | $11,260,761 | dollars as filed | |
| FATE THERAPEUTICS INC | 31189P102 | COM | 3,379,064 | $3,320,268 | dollars as filed | |
| NEUMORA THERAPEUTICS INC. | 640979100 | COM | 1,849,445 | $3,310,507 | dollars as filed | |
| RALLYBIO CORP | 75120L100 | COM | 3,636,363 | $2,494,909 | dollars as filed | |
| LYELL IMMUNOPHARMA INC COM NEW | 55083R203 | Stock | 54,887 | $1,689,422 | dollars as filed | |
| VOR BIOPHARMA INC | 929033207 | COMMON STOCK | 53,732 | $702,815 | dollars as filed | |
| NANO X IMAGING LTD | M70700105 | ORD SHS | 158,852 | $444,786 | dollars as filed | |
| STANDARD BIOTOOLS INC | 34385P108 | COM | 311,967 | $399,318 | dollars as filed | |
| ADICET BIO INC | 007002207 | COM NEW | 22,779 | $191,803 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000904454-26-000111 | superseded | 2026-02-13 | acceptance time not in the bulk data set | |
| 13F-HR/A 0000904454-26-000192 | this filing | 2026-03-18 | acceptance time not in the bulk data set |